Late-Stage

Groupe PARIMA supports late-stage programs by refining early results into repeatable and scalable GMP execution. 

late-stage
Built for repeatability

FROM LATE-STAGE DEVELOPMENT TO VALIDATED MANUFACTURING

Groupe PARIMA supports late-stage programs through technology transfer, process optimization, and validation to establish consistent manufacturing performance and regulatory readiness. At our integrated site, we finalize manufacturing processes, complete process and analytical validation, and generate stability data to support commercial manufacturing.

 

Scale-up and validation secured

We work closely with your team, providing direct access to scientific experts and integrated analytical and production capabilities to secure validation execution and submission timelines.

Reduce scale‑up surprises

Use prior knowledge and confirmatory studies to demonstrate formulation and process robustness at commercial‑relevant batch sizes.

Strengthen methods 

Develop, validate, and transfer analytical methods, generating stability data that supports validation, regulatory submission, and lifecycle management.

Maintain reliable GMP Batches

Support exhibit and validation batches through controlled GMP manufacturing and packaging aligned with PPQ and submission timelines.

Validation driving reliable supply

Groupe PARIMA delivers late‑stage analytical and manufacturing capabilities within a single‑site model. We support tech transfer and validation activities by confirming scale‑up readiness, executing validated analytical methods, and generating technical evidence required for regulatory submission and reliable GMP supply.

01
QBD and DOE approach-

QbD and DoE approach 

We use a Quality by Design approach supported by Design of Experiments to confirm CMA, CPP, and CQA and demonstrate process robustness.

02
tech transfer and validation

Tech transfer and validation

Establish and confirm manufacturing and packaging processes through controlled tech transfer and validation for commercial‑scale production.

03
HPLC

Method robustness and stability studies

Our in-house laboratory executes method development, validation, and transfer, plus stability programs and microbiology testing. 

We work closely with your team to execute late‑stage programs with control, consistency, and predictable performance at scale.

Resources

Explore resources on tech transfer, validation, and analytical and stability data supporting consistent GMP supply.

White papers
2026/07/06
How Drug Product Formulation Works: Topical, Oral, and Nasal Liquid and Semi-Solid Dosage Forms
White papers
2026/07/03
How Early API Characterization Can Reduce Formulation and Scale-up Risks
Blog
2026/07/03
Topical 101: A Guide to Complex Dermatology Formulation Development
White papers
2026/07/06
How Drug Product Formulation Works: Topical, Oral, and Nasal Liquid and Semi-Solid Dosage Forms
White papers
2026/07/03
How Early API Characterization Can Reduce Formulation and Scale-up Risks
Blog
2026/07/03
Topical 101: A Guide to Complex Dermatology Formulation Development

Contact us

Secure your late-stage execution.

Tell us where your program is today, and we’ll support controlled tech transfer and validation through scale‑up and commercialization.